Drug intelligence / Profile preview

hyaluronidase + bupivacaine

Development stage
Unknown
Lead developer
Sohag University
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
Administration
Perineural Injection
01

Overview

Hyaluronidase is a biologic enzyme that acts as a spreading factor by depolymerizing hyaluronic acid, a key component of the extracellular matrix in connective tissues. In clinical research conducted by Sohag University, hyaluronidase is utilized as an adjuvant to the local anesthetic bupivacaine in ultrasound-guided supraclavicular brachial plexus blocks. The primary objective of this combination is to enhance the onset of sensory and motor nerve blocks for patients undergoing upper limb surgery, thereby improving postoperative pain management. By breaking down the interstitial barrier, hyaluronidase facilitates the diffusion of bupivacaine toward the target nerves. The Sohag University study specifically evaluated a dose of 800 IU of hyaluronidase added to 0.375% bupivacaine, demonstrating a significantly faster onset of anesthesia without altering the overall duration of the block.

Other names
hyaluronidase as an adjuvant to bupivacainehyaluronidase-Sohag University-postoperative pain
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on hyaluronidase + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronidase + bupivacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call